Emory's Comprehensive Liver Program
Emory's liver program provides compassionate, individualized care to people suffering from the entire spectrum of liver diseases.
Emory is a leader in liver disease treatment, and to this end we have assembled a multidisciplinary liver team of healthcare professionals whose expertise is unrivaled in the Southeast. That means patients have access to a variety of highly skilled liver specialists, including hepatologists, surgeons, radiologists, pathologists and oncologists. Emory is committed to offering the newest and most effective treatments available, including liver transplantation.
Emory is also at the forefront of liver research. We conduct studies and clinical trials with the goal of advancing the understanding of liver diseases and developing new, more effective liver therapies.
Emory's liver program provides:
- Diagnosis of liver conditions using the most sophisticated diagnostic tools available, including MRI and advanced endoscopy
- Management of all diseases and conditions of the liver
- Cutting-edge treatments including laparoscopic liver resection, interventional radiology, liver transplant, and endoscopic procedures
What Sets Emory Apart?
Here at Emory, patients receive the best possible care from a team of world-renowned experts using state-of-the-art diagnostic tools and therapies. Here are just a few of the things that set Emory apart.
Emory's Video Experience >
Emory has perhaps the greatest expertise and experience in the country with laparoscopic liver resection. We perform a large volume of procedures with excellent outcomes, relying on the combined experience of doctors Juan Sarmiento, David Kooby, Steven Hanish and Shishir Maithel. Rather than the traditional staple
technique, Emory surgeons use the innovative harmonic scalpel, which cuts and cauterizes simultaneously, for a more controlled technique.
Read more...
Emory's Video Experience >
Emory uses a multidisciplinary approach to treating bile duct cancer which involves not only traditional radiation and chemotherapy, but also liver transplantation in appropriate patients. The team encompasses radiation oncology, medical oncology, hepatology and transplant surgery.
Read more...
Until fairly recently, HIV-positive patients were considered ineligible for liver transplantation because of poor outcomes. But Emory is finding success with a special protocol it has developed for HIV-positive liver transplant patients, which involves a multidisciplinary team including infectious disease specialists, hepatologists and liver transplant surgeons.
Read more...
Our team of radiologists is among the world's most experienced experts at magnetic resonance imaging of the liver. This includes the "Virtual Liver Biopsy," that provides the ability to detect disease of the liver, including liver tumors, safely, quickly and without the necessity of a needle biopsy or the use of any other imaging tests that utilize possible cancer causing X-rays.
Read more...
Emory is currently conducting clinical trials with a chemotherapy drug called sorafenib to treat hepatocellular carcinoma.
Emory's team of expert pathologists is dedicated to improving both liver transplant outcomes and the diagnosis of liver tumors.
Emory researchers are studying molecular biomarkers for hepatobiliary malignancy to help personalize cancer care.
Emory researchers are collaborating with the University of California, San Francisco in developing a national clinical trial to monitor post-transplant patients (both pediatric and adult) who are weaned from immunosuppression drugs. Emory is also participating in an ongoing hepatitis C pathogenesis project.
Working in conjunction with Children's Healthcare of Atlanta, Emory doctors René Romero and Stuart Knechtle lead one of the largest pediatric liver transplant programs in the U.S. Dr. Romero is also a principal investigator in the NIH-sponsored Childhood Liver Disease Research and Education Network.
